trending Market Intelligence /marketintelligence/en/news-insights/trending/MK-_2wRfx3G_WCKw4VoSSA2 content esgSubNav
In This List

Kura Oncology prices $50.1M common stock offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Kura Oncology prices $50.1M common stock offering

Kura Oncology Inc. priced an underwritten public offering of 7,700,000 common shares at $6.50 apiece, for expected gross proceeds of about $50.1 million.

The company also granted underwriters a 30-day option to buy up to an additional 1,155,000 common shares.

The offering is expected to close on or around Aug. 16, subject to customary closing conditions.

Leerink Partners and Cowen are acting as joint book-running managers for the offering, with JMP Securities and Oppenheimer & Co. as co-lead managers.